RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Register / XX / DEA-XXX-2026-0001
World Health Organization · XX
DEA-XXX-2026-0001
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
Issuing authority
World Health Organization (WHO)
Authority reference
N°1/2026
Date issued
07 May 2026
Recorded by us
2026-09-06 17:27:54 UTC
Product
ACCUPAQUE (Iohexol), OMNIPAQUE (Iohexol) and VISIPAQUE (Iodixanol)
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Manufacturer
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Batch numbers
Not published with the notice
Expiry dates
Not published with the notice
Action type
Public warning
Classification
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Substandard — cause not stated
Product type
Medicine
ATC code
Not stated by the issuing authority
Affected markets
XX — no market beyond the issuing country was named on the notice
Cross-border event
Substandard iohexol contrast media
Notice text
Not captured. The notice itself is linked below.
Status
Active
Superseded by
Not superseded. This is the current version.
Version
3

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Primary source
https://www.who.int/news/item/07-05-2026-medical-product-alert-n-1-2026--substandard-accupaque-(iohexol)--omnipaque-(iohexol)-and-visipaque--(iodixanol)
Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
52896cd7a089c1a21bf2e51ea8806333c5cccd37c7d06aa65702872395244b52
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:51:37 UTC

Related actions elsewhere

Open the event view →
ReferenceDateCtryProductBatchesActionClassSource
DEA-KE-2026-000907 May 2026KEOmnipaque 350mg
GE HealthCare, Ireland		17212392RecallUnclassifiedTier 1 · Regulator-published
DEA-ZA-2026-006120 Apr 2026ZAContrast media (iohexol)none publishedRecallUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0025Apr 2026EGOmnipaque 300 mg/mlnone publishedRecallClass IITier 1 · Regulator-published
Cite this record
Drug Eye Africa (2026). DEA-XXX-2026-0001: ACCUPAQUE (Iohexol), OMNIPAQUE (Iohexol) and VISIPAQUE (Iodixanol) — Public warning, World Health Organization. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/xx/2026/dea-xxx-2026-0001

Version history

v1Created from the WHO register. No corrections. (correction)
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.

This record as data

/api/v1/notices/DEA-XXX-2026-0001

DEA-XXX-2026-0001 — ACCUPAQUE (Iohexol), OMNIPAQUE (Iohexol) and VISIPAQUE (Iodixanol) · Drug Eye Africa